TiGenix to acquire Cellerix

TiGenix N.V. (Euronext:TIG) will acquire fellow cell therapy company Cellerix S.A. (Madrid, Spain) in a stock deal that values Cellerix at EUR 58

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE